This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
CD81
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref...) |
|||
| Line 1: | Line 1: | ||
| - | |||
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
| - | 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue. | ||
== Function == | == Function == | ||
| + | |||
| + | CD81 is a cell-surface protein involved in a variety of biological responses like adhesion, morphology, activation, proliferation adn differentiation of of B- and T-cells<ref>PMID:9597125</ref>. CD81 belongs to the tetraspanin family - protein containing 4 transmembrane domains - which form microdomains in the cell surface with a variety of partner proteins. | ||
== Disease == | == Disease == | ||
== Relevance == | == Relevance == | ||
| + | |||
| + | CD81 is widely expressed on the majority of tumor cells. Antibodies that target CD81 are a novel treatment against B-cell lymphoma<ref>PMID:31123084</ref>. CD81-defficient mice are impaired in their ability to suppress the anti-tumor immune response. | ||
== Structural highlights == | == Structural highlights == | ||
| Line 17: | Line 19: | ||
==3D structures of CD81== | ==3D structures of CD81== | ||
| - | [[1g8q]] - hCD81 extracellular domain 113-202 - | + | [[5tcx]] - hCD81 (mutant) - human<br /> |
| + | [[1g8q]], [[1iv5]], [[5m3t]], [[5m3d]], [[5m4r]], [[5m33]], [[5m2c]], [[3x0e]], [[3x0f]] - hCD81 extracellular domain 113-202<br /> | ||
| + | [[6ejm]], [[6ek2]], [[6ejg]], [[5dfw]] - hCD81 extracellular domain + Scfv<br /> | ||
| + | [[5dfv]] - hCD81 extracellular domain + antibody<br /> | ||
[[3k0g]] - CD81 extracellular domain - green monkey<br /> | [[3k0g]] - CD81 extracellular domain - green monkey<br /> | ||
| + | [[6u9s]] - CD81 extracellular domain + antibody - mouse<br /> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 07:30, 17 May 2020
| |||||||||||
3D structures of CD81
5tcx - hCD81 (mutant) - human
1g8q, 1iv5, 5m3t, 5m3d, 5m4r, 5m33, 5m2c, 3x0e, 3x0f - hCD81 extracellular domain 113-202
6ejm, 6ek2, 6ejg, 5dfw - hCD81 extracellular domain + Scfv
5dfv - hCD81 extracellular domain + antibody
3k0g - CD81 extracellular domain - green monkey
6u9s - CD81 extracellular domain + antibody - mouse
References
- ↑ Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol. 1998;16:89-109. doi: 10.1146/annurev.immunol.16.1.89. PMID:9597125 doi:http://dx.doi.org/10.1146/annurev.immunol.16.1.89
- ↑ Vences-Catalan F, Kuo CC, Rajapaksa R, Duault C, Andor N, Czerwinski DK, Levy R, Levy S. CD81 is a novel immunotherapeutic target for B cell lymphoma. J Exp Med. 2019 Jul 1;216(7):1497-1508. doi: 10.1084/jem.20190186. Epub 2019 May , 23. PMID:31123084 doi:http://dx.doi.org/10.1084/jem.20190186
